Russia’s RDIF sovereign wealth fund said on Monday a U.S. firm had violated Russian patent rights on its Sputnik V vaccine against COVID-19.
RDIF, which actively markets Sputnik V abroad, did not disclose the name of the U.S. firm.
https://www.reuters.com/article/us-health-coronavirus-russia-vaccine-rig/russia-says-unnamed-u-s-firm-violated-patent-rights-on-sputnik-v-vaccine-idUSKBN2BE1VH
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.